200 related articles for article (PubMed ID: 10619467)
1. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats.
Krasnova IN; Bychkov ER; Lioudyno VI; Zubareva OE; Dambinova SA
Neuroscience; 2000; 95(1):113-7. PubMed ID: 10619467
[TBL] [Abstract][Full Text] [Related]
2. A central 6-hydroxydopamine lesion prevents fluphenazine-induced increase in plasma homovanillic acid.
Labarca R; Thomas JW; Koulu M; Kim YS; Janowsky A; Wilkinson L; Linnoila M; Paul SM; Pickar D
Brain Res Bull; 1988 May; 20(5):567-71. PubMed ID: 3133084
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats.
Boix F; Huston JP; Schwarting RK
Brain Res; 1992 Oct; 592(1-2):181-6. PubMed ID: 1280516
[TBL] [Abstract][Full Text] [Related]
4. Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens.
Boix F; Mattioli R; Adams F; Huston JP; Schwarting RK
Eur J Pharmacol; 1992 May; 216(1):103-7. PubMed ID: 1382019
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex.
Abercrombie ED; Keefe KA; DiFrischia DS; Zigmond MJ
J Neurochem; 1989 May; 52(5):1655-8. PubMed ID: 2709017
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain.
Asanuma M; Ogawa N; Nishibayashi S; Kawai M; Kondo Y; Iwata E
Arch Int Pharmacodyn Ther; 1995; 329(2):221-30. PubMed ID: 8540762
[TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
Lapchak PA; Miller PJ; Collins F; Jiao S
Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
[TBL] [Abstract][Full Text] [Related]
8. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
9. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
Jaffer A; van der Spuy GD; Russell VA; Mintz M; Taljaard JJ
Neurodegeneration; 1995 Jun; 4(2):139-45. PubMed ID: 7583677
[TBL] [Abstract][Full Text] [Related]
10. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
Karoum F; Chrapusta SJ; Egan MF
J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
[TBL] [Abstract][Full Text] [Related]
11. In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment.
Luthman J; Friedemann M; Bickford P; Olson L; Hoffer BJ; Gerhardt GA
Neuroscience; 1993 Feb; 52(3):677-87. PubMed ID: 7680793
[TBL] [Abstract][Full Text] [Related]
12. [The influence of substance P central administration on ethanol intake in rats chronically exposed to alcohol].
Nikolaev SV; Bychkov ER; Lebedev AA; Dambinova SA
Ross Fiziol Zh Im I M Sechenova; 2002 Jul; 88(7):907-13. PubMed ID: 12238360
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
Rivest R; Jolicoeur FB; Marsden CA
Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
[TBL] [Abstract][Full Text] [Related]
14. Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats.
Invernizzi R; Pozzi L; Samanin R
Brain Res; 1995 Jan; 670(1):165-8. PubMed ID: 7719718
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the influences of the central administration of substance P on ethanol consumption in chronically alcoholic rats.
Nikolaev SV; Bychkov ER; Lebedev AA; Dambinova SA
Neurosci Behav Physiol; 2003 Nov; 33(9):905-9. PubMed ID: 14969430
[TBL] [Abstract][Full Text] [Related]
16. Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures.
Antkiewicz-Michaluk L; Romańska I; Vetulani J
Psychopharmacology (Berl); 1996 Nov; 128(1):39-44. PubMed ID: 8944404
[TBL] [Abstract][Full Text] [Related]
17. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.
Rosin DL; Clark WA; Goldstein M; Roth RH; Deutch AY
Neuroscience; 1992 Jun; 48(4):831-9. PubMed ID: 1352864
[TBL] [Abstract][Full Text] [Related]
20. A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance.
McCullough LD; Sokolowski JD; Salamone JD
Neuroscience; 1993 Feb; 52(4):919-25. PubMed ID: 8450978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
